JP Morgan Maintains Neutral Rating for Cardinal Health: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
JP Morgan has maintained a Neutral rating for Cardinal Health (NYSE:CAH) and increased its price target from $101.00 to $112.00. Cardinal Health's shares are currently trading at $103.30, and the new price target suggests an 8.42% potential upside. Cardinal Health is a major player in the U.S. pharmaceutical wholesale industry, alongside Cencora and McKesson, and also supplies medical-surgical products globally.
November 17, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan maintains a Neutral rating on Cardinal Health but raises the price target from $101 to $112, suggesting an 8.42% upside from the current trading price of $103.30.
The increase in price target by JP Morgan is a positive signal for investors, indicating a potential upside for Cardinal Health's stock. While the rating remains Neutral, the raised target price could lead to increased investor confidence and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100